Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Adamo Foods

Adamo Foods Nets $2.5M to Bring Groundbreaking Clean-Label Mycelium Steak to Market

14th August 2024

Proprietary Fermentation Process Mimics the Muscle Structure of Whole-Cut Meat, Promoting Health with Zero Cholesterol and Reducing Emissions by 93%.
UK-based technology startup Mirico

Laser Targeting: Methane-chasing startup Mirico raises $2.0M

13th June 2024

UK-based technology startup Mirico has raised a successful funding round to support its distinctive laser-based sensing and data analytics platform, which is initially focused on finding and eliminating methane leaks from oil & gas infrastructure.
Patient having temperature taken.

MoD spin-out Presymptom Health raises £1.5m to develop AI-driven sepsis and infection tests for the NHS

22nd March 2024

UK start-up Presymptom Health has raised £1.5m in follow-on seed and grant funding that will help accelerate time to market of its AI-driven sepsis and infection tests.
image of presympton health

UKI2S portfolio company, Presymptom Health, joins government pilot

15th February 2024

To get AI-driven infection test into the NHS faster helping to tackle Anti-Microbial Resistance.
Productive Machines Technologies

Improve efficiency, productivity and sustainability with Productive Machines

30th January 2024

NetZero by 2030. Responsible investment. Environmental action. Social inclusion. Impact-first – that’s the mission. The driving force behind UKI2S.
Oxford Space Systems

Oxford Space Systems’ £3M Funding Round, Supported by UK Ministry Of Defence contributed through UKI2S

9th January 2024

Supported by UK Ministry Of Defence contributed through UKI2S. Oxford Space Systems announces the successful completion of a £3 million equity investment…
An image of the Grand Prismatic Spring (licensed from photographer Werner van Steen), representing the origin of our sulfur-utilizing mitochondrial ancestors

MitoRx Therapeutics Announces Close of Seed Extension Financing Round

13th December 2023

To Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases.
IFAST in the lab

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

17th February 2023

Bacterial resistance to antibiotics is growing as a critical worldwide challenge, often stated as the next potential pandemic.
Iain Miller, CEO of PreSymptom Health

CEO Spotlight: Iain Miller, CEO of PreSymptom Health

6th December 2022

You develop an instinct through your career. Like an experienced driver, you start to see problems before they happen, you come to know that the car at the junction ahead might come out…
Gary Owen, CEO of Lineat Composites

CEO Spotlight: Gary Owen, CEO of Lineat Composites

24th October 2022

As the world transitions towards hydrogen storage, there is increasing demand for storage vessels which are made from carbon fibre.

X-ray image

Silveray announces £2.2M seed round for ultra-efficient X-ray detector technology

12th October 2022

Surrey University spin-out company raises £1.5M in a seed round led by UKI2S to commercialise a novel nano-material that makes X-ray detectors more efficient and promises a more viable route to wide area detector panels.
lab work

NAMSA acquires UK-based Perfectus Biomed Group to enhance customised microbiological solutions

5th October 2022

NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group…
Artist impression Drax panamax with FastRigs

Smart Green Shipping announces £5m investment into FastRig wing sail technology

28th July 2022

Three-year project backed by the Scottish Government and industry will develop and test fully automated, emission-reduction sail technology that can be retrofitted to merchant ships.
Oxford Space Systems

UK space companies’ partnership completed the development of an advanced deployable SAR antenna payload

22nd July 2022

Oxford Space Systems (OSS) and Surrey Satellite Technology Ltd (SSTL) have completed the build of an innovative deployable Synthetic Aperture Radar (SAR) antenna payload for the next…
Jon Rees, CEO of MitoRx Therapeutics

CEO Spotlight: Jon Rees, CEO of MitoRx Therapeutics

20th July 2022

MitoRx is a preclinical research stage biotechnology company developing first-in-class, orally available, mitochondrial protective therapeutics targeting rare…
Mirico

Mirico accelerates climate change monitoring with investment led by Shell Ventures

18th July 2022

Mirico announced today that it had raised £2m to accelerate roll out of its greenhouse gas emissions monitoring solutions.

Damien Weidmann

CSO Spotlight: Damien Weidmann, CSO of Mirico

31st May 2022

The main market that we are addressing relates to greenhouse gases because of the need to measure and monitor them to control emissions.
bioprocessing technology

MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases

25th April 2022

MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases…
Lab work

HydRegen receives funding to implement their proprietary enzyme platform into sustainable chemical processes

1st March 2022

HydRegen, the revolutionary bioscience company, enables sustainable chemical manufacturing using their proprietary enzyme based redox platform.
Cows

Mirico monitors impact of cattle grazing and fertiliser strategies on agricultural greenhouse gas emissions

1st March 2022

Mirico is collaborating with partners in the agricultural sector to baseline and understand greenhouse gas emissions associated with cattle farms, helping with sector plans to reach net zero.
OSS banner

Oxford Space Systems in ground-breaking programme for Innovative Space Solutions

1st February 2022

Oxford Space Systems (OSS) has announced an investment round, subject to final completion, of approximately £4 million to accelerate development of its existing deployable antenna…
Medication

CellCentric secures investment from the American Cancer Society’s impact venture capital fund

26th January 2022

Inobrodib is the first drug to target p300/CBP, a new way to treat specific cancers.  Following a successful Phase I campaign, new funding will be used to…
Gherkin

Review of 2021

21st January 2022

A year of global challenges emphasises the role of science and technology in our changing world.
Viewing screen

Helix Geospace raises £3m Seed funding to take its world-leading GPS antennas into mass production

17th December 2021

Helix Geospace, the leading innovator in antenna and RF (radio frequency) technology, is pleased to announce that it has raised £3million seed funding in a round led by Bloc Ventures.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.